Micro-RNA-195 and -451 regulate the LKB1/AMPK signaling axis by targeting MO25

Hao Chen, Gustavo M. Untiveros, Laurel A.K. McKee, Jessica Perez, Jing Li, Parker B. Antin, John P. Konhilas

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Abstract

Background: Recently, MicroRNAs (miR) and AMP-kinase (AMPK) have emerged as prominent players in the development of cardiac hypertrophy and heart failure. We hypothesized that components of the adenosine monophosphate-activated kinase (AMPK) pathway are targeted by miRs and alter AMPK signaling during pathological cardiac stress. Methodology/Principal Findings: Using a mouse model of hypertrophic cardiomyopathy (HCM), we demonstrated early elevation of miR-195 and miR-451 in HCM hearts, which targets MO25, a central component of the MO25/STRAD/LKB1 complex that acts as an upstream kinase for AMPK. We show functional targeting of MO25 by miR-195 and -451. Further in vitro interrogation of MO25 as a functional target validated this hypothesis where over-expression of miR-195 in C2C12 cells knocked down MO25 expression levels and downstream AMPK signaling (phosphorylation of Acetyl CoA carboxylase [ACC] and AMPK activity assay), similar to MO25 knockdown in C2C12 cells by siRNA. Parallel changes were measured in 60 day R403Q HCM male hearts that were rescued by short-term administration of AICAR, an AMPK agonist. Conclusions/Significance: Elevated miR-195 targets the LKB1/AMPK signaling axis in HCM progression and implicates a functional role in HCM disease progression. MiR-195 may serve as potential therapeutics or therapeutic targets for heart disease.

Original languageEnglish (US)
Article numbere41574
JournalPloS one
Volume7
Issue number7
DOIs
StatePublished - Jul 23 2012

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Micro-RNA-195 and -451 regulate the LKB1/AMPK signaling axis by targeting MO25'. Together they form a unique fingerprint.

Cite this